Trial Profile
A Phase I, Open-Labelled Study of Upadacitinib in Healthy Male and Female Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Nov 2017
Price :
$35
*
At a glance
- Drugs Upadacitinib (Primary) ; Rifampicin
- Indications Autoimmune disorders
- Focus Adverse reactions; Pharmacodynamics
- 02 Nov 2017 New trial record